415 related articles for article (PubMed ID: 17627791)
1. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
Sterry W; Strober BE; Menter A;
Br J Dermatol; 2007 Oct; 157(4):649-55. PubMed ID: 17627791
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects and comorbidities of psoriasis.
Ayala F; Ayala F
J Rheumatol Suppl; 2009 Aug; 83():19-20. PubMed ID: 19661531
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis as the marker of underlying systemic disease.
Kourosh AS; Miner A; Menter A
Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis and the metabolic syndrome.
Alsufyani MA; Golant AK; Lebwohl M
Dermatol Ther; 2010; 23(2):137-43. PubMed ID: 20415820
[TBL] [Abstract][Full Text] [Related]
5. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community.
Menter A; Griffiths CE; Tebbey PW; Horn EJ; Sterry W;
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1371-7. PubMed ID: 20384692
[TBL] [Abstract][Full Text] [Related]
6. The concept of psoriasis as a systemic inflammation: implications for disease management.
Reich K
J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis: an opportunity to identify cardiovascular risk.
Federman DG; Shelling M; Prodanovich S; Gunderson CG; Kirsner RS
Br J Dermatol; 2009 Jan; 160(1):1-7. PubMed ID: 19016698
[TBL] [Abstract][Full Text] [Related]
8. Obesity-related cardiovascular disease: implications of obstructive sleep apnea.
Wolk R; Somers VK
Diabetes Obes Metab; 2006 May; 8(3):250-60. PubMed ID: 16634984
[TBL] [Abstract][Full Text] [Related]
9. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation.
Bremmer S; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Blauvelt A;
J Am Acad Dermatol; 2010 Dec; 63(6):1058-69. PubMed ID: 20692722
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities in patients with psoriasis.
Gottlieb AB; Dann F
Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis comorbidities.
Gottlieb AB; Chao C; Dann F
J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognosis in patients with psoriasis.
Gulliver W
Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis and the metabolic syndrome.
Gottlieb AB; Dann F; Menter A
J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588
[TBL] [Abstract][Full Text] [Related]
14. Metabolic comorbidities and psoriasis.
Gisondi P; Ferrazzi A; Girolomoni G
Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis, the liver, and the gastrointestinal tract.
Gisondi P; Del Giglio M; Cozzi A; Girolomoni G
Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
Boehncke WH; Boehncke S
G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
[TBL] [Abstract][Full Text] [Related]
18. Research in practice: the systemic aspects of psoriasis.
Boehncke WH; Boehncke S
J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
Gisondi P; Girolomoni G
Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
[TBL] [Abstract][Full Text] [Related]
20. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
